ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

EDEN Eden Research Plc

4.35
0.15 (3.57%)
17 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 3.57% 4.35 4.10 4.60 4.60 4.20 4.20 1,035,391 14:54:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.36 23.2M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.20p. Over the last year, Eden Research shares have traded in a share price range of 3.675p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £23.20 million. Eden Research has a price to earnings ratio (PE ratio) of -10.36.

Eden Research Share Discussion Threads

Showing 17226 to 17245 of 18225 messages
Chat Pages: Latest  693  692  691  690  689  688  687  686  685  684  683  682  Older
DateSubjectAuthorDiscuss
13/2/2024
10:33
So Investors who have heard our case they listen note and monitor . And act when the things they've been told start to come true.I'm trying to say fundamentals are key.I'm discounting success others aren't but might as time passes.At 30 mill Marcap I'm surely discounting 1 million profit.
alchemy
13/2/2024
10:30
Certainty of survival that's to say break even and constant cash for most purposes here roughly the same . I suggest £ 8 million at 50% margin .Two more years at 1.7 growth ie three years at thst rate including last year. New countries new products coming on stream ?
alchemy
13/2/2024
10:28
There is no certainty of survival. Huge companies go into administration after many years of trading.

You have to build appetite and you do that through understanding. That's the size of the Eden opportunity and how that translates into share price.

I'm not aware we have ever made that clear.

investingisatrickygame
13/2/2024
10:26
I don't know about fewer sellers emanating from the recent cash raising. Were all the shares for financial engineering i e to set against tax etc ?If that's the headwind who can tell me when it ends , how big the pile is etc?
alchemy
13/2/2024
10:23
The key to an increased price . How I wish I knew how I wish I really really knew . Ok more buys than sells. That's a start, Some ideas Certainty of survival Increased turnoverFewer sells of shares
alchemy
13/2/2024
09:24
One man, so much bravado, such inventiveness with the 30+ fake IDs, his employer or maybe just payer will ensure they can escape liability by hanging him out to dry, for the scale and duration of the fraud is such as to suggest a custodial sentence at the upper end of the scale.... FIFTEEN YEARS IMPRISONMENT notwithstanding it being a first relevance offence.

;D

Shame that his PI accomplice, perhaps due to age and obvious infirmity ("your Hon., if my client wasn't mad he wouldn't have ""invested"" X numptillion into HADES, and he's lost all of that, so mercy is justified." or "Dear CPS, a G-plea in exchange for three years") he will escape more lightly.

Cucumber but not the way a tool uses it?

neutralpov
13/2/2024
03:14
Syngenta / Paraquat in the courts
money never sleeps
12/2/2024
21:06
Eden has done a series of PR/IR exercises for a US audience now and it would appear to me, no takers thus far. I haven't seen a volume change to suggest so. That said, the pragmatic amongst us accept that it takes time. Even so, allowing for those events, there has been enough time for some to come into the market and buy stock.

The share price sits at 5.625p showing a MCap of circa £30 million which would be even less, but for the recent increase in the number of shares in issue following a capital raise.

'Our' share price has made NO progress in the last 5+ years, yet the Company has increased regulatory approvals, label extensions & NPD such as Ecovelex.

There is one known major announcement left to come and it is our insecticide. Treating 4 insects as opposed to the standard 2, we wait to see if we will deal with one global partner or several partners. After this announcement, there is no known new products to be announced and the known future is regulatory approvals, as and when and label extensions, as and when. Even if there are new products, they will be and revenue will be a minimum 3 years away which Eden has stated itself.

So if the insecticide announcement doesn't substantially move our share price, what will and when?

To me, the insecticide is a pivotal moment. If Eden doesn't grab the attention of the investment community with that announcement and the share price doesn't factor in future income and possibilities then to me, others may well disagree, Eden looks vulnerable.

Others with deeper pockets may well see that those pockets are better able to more quickly deliver revenue in a sustainable way that perhaps, Eden cannot. For all of Eden's ingenuity and know how, as a public company, they have to satisfy the investment community & shareholders and a continued inability to do that, as evidenced by the share price, can surely only lead to one outcome.

We can't talk about global expansion, 19 countries, some products that have been available for years, but with revenue subject to weather (an unknown every year and difficult if not impossible to financially forecast) and at the same time talk about $billion markets without penetration in any meaningful way.

Either we have the capability now to sell tens of $millions of product as AttyG has suggested, or we don't. If we do, then the investment proposition has to be sold more appropriately, more aggressively, such that it is sufficiently realised to create investment momentum, something I am not sure I have ever seen in Eden.

investingisatrickygame
12/2/2024
18:23
Time for another megadilution? This c-nt doesn't yet grasp division....
neutralpov
12/2/2024
18:22
ROTFLMAOOOO

Ill can be cured
Mentally ill can be medicated
But

There's no cure for stoooopid.

neutralpov
12/2/2024
15:45
I’ll be topping up soon, don’t worry. But thanks for your advice!
kittybiscuits
12/2/2024
11:40
Hi crooks!

Promise I will arrange for "special" prison visits once we have you banged up!

Heh.

neutralpov
11/2/2024
17:29
The agrotoxic lobby's sabotage of pesticide reduction in the EU triumphs.



Corteva Europe
@CortevaEUR
·
9 Feb
It is the International Day of Women and Girls in Science 👩🏽‍🔬 this Sunday, and the perfect time to learn more about the gender gap that continues to persist in the industry.

Weaponised virtue signalling. ..ESG lol

supersonico
11/2/2024
16:50
Slide 22
The pipeline of products that Eden is developing covers the following addressable markets / applications.


Cannabis.





Cannabis..this could be as a fungicide for Cannabis plants or as encapsulated cannabis oil application that is TT / Elanco related imo
..................


Elanco / TT ..inthecomingshortorder



WO2024026383 - YEAST PARTICLES FOR DELIVERY OF WATER-ACTIVATED SELF-EMULSIFYING CANNABINOID FORMULATIONS

Agricultural and Industrial Compositions and Methods

The compositions and methods of the present disclosure are useful in the fields of consumer and industrial products, e.g., in food, human and animal drugs, cosmetics, and agriculture. In some embodiments, the compositions and methods of the present disclosure extend to agricultural applications. In certain embodiments, the present disclosure relates to the development and delivery of stable and controlled-release microbiocides, fungicides, insecticides, nematocides, and pesticides to agricultural species, e.g., plants and/or animals. In certain exemplary embodiments, the present disclosure relates to the development and delivery of stable and controlled-release cannabinoids to agricultural species, e.g., animals such as livestock or pets.

In some embodiments of the present disclosure, any of the compositions described above may be formulated in a deliverable form suited to a particular application. Deliverable forms that can be used in accordance with embodiments of the present disclosure include, but are not limited to, liquids, emulsions, emulsifiable concentrates, solids, aqueous suspensions, oily dispersions, pastes, granules, powders, dusts, fumigants, and aerosol sprays. Suitable deliverable forms can be selected and formulated by those skilled in the art using methods currently known in the art. The compositions can be provided in combination with an agriculturally, food, or pharmaceutically acceptable carrier or excipient in a liquid, solid, or gel-like form. For solid compositions, suitable carriers include pharmaceutical or food grades of mannitol, lactose, starch, magnesium stearate, sodium saccharin, talc, cellulose, glucose, sucrose, and magnesium carbonate. Suitably, the formulation is in tablet or pellet form. As suitable carrier could also be a human or animal food material. Additionally, conventional agricultural carriers could also be used.

supersonico
11/2/2024
12:23
And that would be you would it? Smartest guy in every room, first in every subject and best at every exam. If that is the case, why do you waste your time on this chat board, year after year?
kittybiscuits
11/2/2024
11:45
Hahahahahaha as if the opinion of paid prossers is of any value whatsoever, except to the pimp.

Truly, can these scamsters here on this DB possibly be any more deluded or crooked or both?

(chortle)

neutralpov
11/2/2024
11:04
Timbo_Slice said

"Clearly there is an overhang from the fund raise and sentiment will not change until EDEN make sustainable profits."

I believe Cavendish has a price target now of 20p!

In my opinion, the Cavendish sales team should be supporting & pushing the Company to new investors given we are circa 6p. 14pence worth of headroom to sell into.

They clearly believe Eden is now undervalued and the Company would do well to better promote the share price prospects for Eden in line with Cavendish targets.

investingisatrickygame
11/2/2024
09:51
It's intriguing following this a penny now is a bigger percentage than will be ten at seventy . So accumulating now might be a good thing but we can't all add and even if we do only a little .Most of us are certain the main direction Is up, but there will still be a Scintilla of Fear,So forecasting when the overhang will go and upcoming news is key .
alchemy
11/2/2024
07:36
KB, I disagree. Cumulative increases to share price tell its own story and so much the better if/when there is 'big news'. Clearly there is an overhang from the fund raise and sentiment will not change until EDEN make sustainable profits.
timbo_slice
10/2/2024
10:47
Six pence, none the richer.
ravenna23
Chat Pages: Latest  693  692  691  690  689  688  687  686  685  684  683  682  Older

Your Recent History

Delayed Upgrade Clock